VPViktor Pasovski

Viktor Pasovski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Viktor Pasovski has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Migraine Prevalence and QALY Loss in Serbia: A Population-Level Stratified Modeling Study

    by Viktor Pasovski, Mark Parker, Tanja Novaković, Milica Krga Rastović, Katarina Katanić Pasovski, Ranko Raičević

    Purpose: To estimate age- and sex-specific migraine prevalence in Serbia and annual quality-adjusted life-year (QALY) loss among adults with definite or probable migraine using a population-level stratified model. Methods: Global Burden of Disease (GBD) 2023 prevalence estimates for definite migraine, probable migraine, and total medication-overuse headache (MOH) in Serbia were applied to final 2022 Serbian Census counts by single year of age and sex; 73.2% of total MOH was attributed to migraine. Epidemiological estimates included residents aged 5 years or older, whereas the primary one-year QALY analysis included adults aged 18 years or older with definite or probable migraine. Annual QALY loss equaled modeled case counts multiplied by the GBD 2023 proportion of time symptomatic and the paired EQ-5D-5L migraine-day utility decrement of 0.364. A 100,000-iteration probabilistic sensitivity analysis sampled 12 symptom-time parameters and one shared utility-decrement parameter from normal distributions truncated to [0,1], with prevalence fixed. No episodic/chronic split or attack-frequency assumptions were imposed. Results: The model estimated 952,369 residents aged 5 years or older with migraine (crude modeled prevalence, 15.0%). Among adults, 794,380 with definite or probable migraine were included in the primary QALY analysis, whereas 85,364 with MOH attributable to migraine were reported epidemiologically only. Deterministic annual QALY loss was 21,951, or 0.0276 QALY (10.1 full-health-equivalent days) per included adult. Across 100,000 probabilistic iterations, mean annual loss was 21,949 QALYs (95% uncertainty interval, 20,203– 23,736). Conclusion: Migraine represents a substantial modeled population-health burden in Serbia. The primary estimate excluded pediatric, MOH-related, and additional interictal QALY loss. It provides a transparent national benchmark for migraine recognition, referral, health-related quality-of-life measurement, and evaluation of preventive-care access, but does not establish intervention effectiveness or cost-effectiveness.

  • Open Access

    Silent Retinal Neurodegeneration in Multiple Sclerosis: Structural Evidence from Clinically Unaffected Eyes Using Swept-Source OCT and OCT Angiography—A Cross-Sectional, Observational Study

    by Katarina Katanić Pasovski, Ivana Todorović, Viktor Pasovski, Dragana Ristić, Zorana Pavlović, Miloš Danilović, Nemanja Rančić, Tatjana Bošković Matić, Ranko Raičević, Evica Dinčić

    Background/Objectives: Retinal optical coherence tomography (OCT) has emerged as a sensitive biomarker of neurodegeneration in multiple sclerosis (MS), yet eyes without overt optic neuritis (ON) are routinely pooled as “clinically unaffected” despite their heterogeneous histories. We evaluated whether never-ON eyes and fellow eyes after unilateral ON differ structurally and microvascularly using swept-source OCT (SS-OCT) and OCT angiography (OCTA). Methods: In this cross-sectional, single-center study, 126 clinically unaffected MS eyes—96 never-ON eyes and 30 fellow eyes after unilateral ON—were compared with 118 healthy control eyes. SS-OCT quantified ganglion cell–inner plexiform layer (GCIPL), peripapillary retinal nerve fiber layer (pRNFL), and macular RNFL (mRNFL) thickness, while OCTA measured superficial vascular plexus (SVP) vessel density. Between-group differences were assessed using generalized estimating equations with participant-level clustering, empirical (sandwich) standard errors, adjustment for age and sex, and false discovery rate correction. Results: Despite preserved visual acuity, both never-ON and fellow eyes showed structural retinal thinning relative to controls. GCIPL thickness followed a stepwise gradient—66.14 ± 4.31, 62.08 ± 7.03, and 58.03 ± 7.71 µm in controls, never-ON eyes, and fellow eyes, respectively (FDR-adjusted q = 0.020 for fellow vs. never-ON eyes)—and pRNFL and mRNFL showed a similar overall pattern. After false discovery rate correction, OCTA parameters did not differ significantly between groups. Conclusions: Clinically unaffected eyes in MS are not structurally normal, and fellow eyes after unilateral ON carry a greater burden of silent retinal damage than never-ON eyes. These two phenotypes should be analyzed separately in MS imaging research. Structural OCT measures, particularly GCIPL thickness, appear more sensitive than microvascular indices for detecting subclinical retinal involvement.

  • Open Access

    Unrecognized severe obstructive sleep apnea as a dominant risk factor for non-arteritic anterior ischemic optic neuropathy in an apparently healthy patient

    by Katarina Katanic-Pasovski, Martin Popevic, Viktor Pasovski, Sanja Petrovic-Pajic, Kristina Iklozan, Nemanja Rancic, Mirko Resan, Ranko Raicevic

    Introduction. Non-arteritic anterior ischemic optic neuropathy (NAION) is typically manifested by sudden, pain-less vision loss in one eye, often immediately upon waking up. The visual loss remains fairly stable over time but can be followed by similar manifestations in the fellow eye. One of the main causes for NAION is impaired hemodynamic regulation, followed by hypoperfusion of the optic nerve head. Recognized risk factors include arterial hyper-tension, hyperlipidemia, diabetes mellitus, smoking, etc. Case report. A 43-year-old man with a sudden painless right eye vision loss and typical symptoms and signs of NAION is presented. The ophthalmological examination, followed by fluorescein angiography and visual field testing, confirmed the diagnosis, while medical history had not revealed any of the standard risk factors. During hospitalization, the medical staff noted that the patient was snoring, waking up during the night while feeling short of breath, followed by excessive daytime sleepiness, which was later confirmed by family members as symptoms that had been present for several months. The patient was referred to a somnologist, who, after diagnostics, confirmed the presence of severe, untreated obstructive sleep apnea (OSA) and indicated treatment with a continuous positive air pressure (CPAP) device. The patient responded well to treatment, showing subjective and objective improvements in sleep quantity and quality. No progression of right eye NAION or vision impairments in the left eye has been noted after 6 months from diagnosis and CPAP introduction. Conclusion. OSA was probably the main underlying cause of NAION in this patient. We point out that OSA screening in high-risk patients can contribute to the early diagnosis and prevention of NAION.